Genelyticasp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
Genelytica is a Polish clinical research organization specializing in Phase I–III trials of medical devices and radiopharmaceuticals. It conducts trials aligned with EU MDR and FDA requirements and provides CRO services including trial management, pharmacovigilance, quality assurance, and regulatory affairs across 15 countries.
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2023 – the filing deadline has passed. 3 of 5 financial statements were filed late (the longest delay 483 days for 2021).
- 2023not filed
- 202207/11/2023
- 202110/11/2023
- 202007/02/2022
- 201911/08/2020
- 201814/06/2019
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2022.
Results vs industry
Industry
Offer
- Medical device clinical trials
- Radiopharmaceutical clinical trials
- Clinical trial protocol design
- Clinical trial management
Website technology
- Analytics and marketing
- Google Analytics
Authorized Representatives
Manner of representation
A declaration of will on behalf of the company is made by the President of the Management Board. In the case of a multi-member management board, each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Agnieszka Milewska Krancage 44 | 99 | $1,337.12 | 99% |
Others | 1 | $13.51 | 1% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
5 public aid cases recorded, with a total value of $7,094.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $902$902 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 19, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $3,077$3,077 | Polski Fundusz Rozwoju S.A. | |
| Jun 5, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | STAROSTA POWIATU ŁOMŻA |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Scientia Crosp. z o.o. | $607,622.19 | scientiacro.com | ||
| CTI Clinical Trial and Consulting Services Polandsp. z o.o. | $527,145.56 | ctifacts.com | ||
| CCTSsp. z o.o. | $281,193.31 | ccts.pl | ||
| Specjalistyczne Gabinetysp. z o.o. | $239,872.14 | specjalistycznegabinety.pl | ||
| TCIsp. z o.o. | $218,471.87 | tci.pl | ||
| Nexbiosp. z o.o. | $186,582.40 | nexbio.pl | ||
| Countess Laboratoriessp. z o.o. | $164,970.29 | countess.pl | ||
| Gcp-Service International Ltd. & Co. KgBranch (foreign co.) | $159,376.34 | gcp-service.com | ||
| Pharmaxi Polandsp. z o.o. | $152,292.34 | pharmaxi.com.ua | ||
| Medical Synergiessp. z o.o. | $104,878.60 | medicalsynergies.pl |
Change history
| Date | Event | |
|---|---|---|
| 2018-11-22 | Address change (Ul. Gen. Władysława Sikorskiego 166/003, 18-400, Łomża → Ul. Akademicka 48a, 18-400, Łomża) | |
| 2018-05-29 | Address change (Ul. Jurija Gagarina 5/102, 87-100, Toruń → Ul. Gen. Władysława Sikorskiego 166/003, 18-400, Łomża) | |
| 2018-05-29 | PKD change (Removed: 63.12.Z, 77.40.Z; Added: 32.50.Z, 47.74.Z, 86.90.A, 86.90.E) | |
| 2015-12-11 | Entered in the register |
FAQ
Last updated: 2026-04-15